Intra-Cellular Therapies Inc
F:23I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intra-Cellular Therapies Inc
F:23I
|
US |
|
Northern Shield Resources Inc
XTSX:NRN
|
CA |
|
M
|
Mothercare PLC
F:MTR
|
UK |
|
P
|
Principal Technologies Inc
XTSX:PTEC
|
CA |
|
R
|
Resouro Strategic Metals Inc
XTSX:RSM
|
CA |
|
Sintana Energy Inc
XTSX:SEI
|
CA |
|
Skychain Technologies Inc
XTSX:SCT
|
CA |
|
Canada Silver Cobalt Works Inc
XTSX:NTH
|
CA |
|
Modi's Navnirman Ltd
NSE:MODIS
|
IN |
|
P
|
ProbeLeader Co Ltd
TPEX:5246
|
TW |
|
M
|
Mondo TV SpA
F:MJE
|
IT |
|
Q
|
Quad/Graphics Inc
F:QGU
|
US |
|
C
|
CSB Financial Inc
OTC:CSBA
|
US |
|
Northern Ocean Ltd
OTC:NTNOF
|
BM |
|
C
|
Churchill Downs Inc
XMUN:CHR
|
US |
|
D
|
Dore Copper Mining Corp
OTC:DRCMF
|
CA |
|
M
|
Microcosm Technology Co Ltd
TPEX:3354
|
TW |
|
C
|
Camino Minerals Corp
SWB:XC01
|
CA |
|
Lexinfintech Holdings Ltd
NASDAQ:LX
|
CN |
|
BICO Group AB
F:49Z
|
SE |
|
A
|
Avantium NV
F:27V
|
NL |
|
E
|
Enterprise Metals Ltd
F:RM9
|
AU |
|
AAC Clyde Space AB
F:MKC
|
SE |
|
City View Green Holdings Inc
F:CVY
|
CA |
Bankruptcy Probability
Intra-Cellular Therapies Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Intra-Cellular Therapies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Intra-Cellular Therapies Inc
NASDAQ:ITCI
|
14B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
652.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
333.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
256.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Intra-Cellular Therapies Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Intra-Cellular Therapies Inc has no debt.
You can find a full breakdown on its Balance Sheet.
